These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
818 related articles for article (PubMed ID: 30708032)
21. Inhibitory effects of Ponciri Fructus on testosterone-induced benign prostatic hyperplasia in rats. Jeon WY; Kim OS; Seo CS; Jin SE; Kim JA; Shin HK; Kim YU; Lee MY BMC Complement Altern Med; 2017 Aug; 17(1):384. PubMed ID: 28774334 [TBL] [Abstract][Full Text] [Related]
23. NF-κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance. Austin DC; Strand DW; Love HL; Franco OE; Grabowska MM; Miller NL; Hameed O; Clark PE; Matusik RJ; Jin RJ; Hayward SW Prostate; 2016 Aug; 76(11):1004-18. PubMed ID: 27197599 [TBL] [Abstract][Full Text] [Related]
24. Effect of Choi YJ; Kim EK; Fan M; Tang Y; Hwang YJ; Sung SH Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31591335 [No Abstract] [Full Text] [Related]
25. Baicalin alleviates benign prostate hyperplasia through androgen-dependent apoptosis. Jin BR; An HJ Aging (Albany NY); 2020 Feb; 12(3):2142-2155. PubMed ID: 32018227 [TBL] [Abstract][Full Text] [Related]
26. Effects of Lespedeza Cuneata aqueous extract on testosterone-induced prostatic hyperplasia. Park BK; Kim CW; Kwon JE; Negi M; Koo YT; Lee SH; Baek DH; Noh YH; Kang SC Pharm Biol; 2019 Dec; 57(1):90-98. PubMed ID: 30724641 [TBL] [Abstract][Full Text] [Related]
27. Inhibitory activities of some traditional Chinese herbs against testosterone 5α-reductase and effects of Cacumen platycladi on hair re-growth in testosterone-treated mice. Zhang B; Zhang RW; Yin XQ; Lao ZZ; Zhang Z; Wu QG; Yu LW; Lai XP; Wan YH; Li G J Ethnopharmacol; 2016 Jan; 177():1-9. PubMed ID: 26571086 [TBL] [Abstract][Full Text] [Related]
28. Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms--action of two new agents. Kumar R; Verma V; Sarswat A; Maikhuri JP; Jain A; Jain RK; Sharma VL; Dalela D; Gupta G Invest New Drugs; 2012 Apr; 30(2):582-93. PubMed ID: 21181231 [TBL] [Abstract][Full Text] [Related]
29. Pao Pereira Extract Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by inhibiting 5α-Reductase. Liu J; Fang T; Li M; Song Y; Li J; Xue Z; Li J; Bu D; Liu W; Zeng Q; Zhang Y; Yun S; Huang R; Yan J Sci Rep; 2019 Dec; 9(1):19703. PubMed ID: 31873149 [TBL] [Abstract][Full Text] [Related]
30. The prevention and treatment effects of tanshinone IIA on oestrogen/androgen-induced benign prostatic hyperplasia in rats. Wang C; Du X; Yang R; Liu J; Xu D; Shi J; Chen L; Shao R; Fan G; Gao X; Tian G; Zhu Y; Zhang J J Steroid Biochem Mol Biol; 2015 Jan; 145():28-37. PubMed ID: 25290459 [TBL] [Abstract][Full Text] [Related]
31. Ulmus macrocarpa Hance improves benign prostatic hyperplasia by regulating prostatic cell apoptosis. Rho J; Seo CS; Park HS; Wijerathne CU; Jeong HY; Moon OS; Seo YW; Son HY; Won YS; Kwun HJ J Ethnopharmacol; 2019 Apr; 233():115-122. PubMed ID: 30508623 [TBL] [Abstract][Full Text] [Related]
32. Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase. Choi HM; Jung Y; Park J; Kim HL; Youn DH; Kang J; Jeong MY; Lee JH; Yang WM; Lee SG; Ahn KS; Um JY Sci Rep; 2016 Aug; 6():31906. PubMed ID: 27549514 [TBL] [Abstract][Full Text] [Related]
33. Role of the phytoestrogenic, pro-apoptotic and anti-oxidative properties of silymarin in inhibiting experimental benign prostatic hyperplasia in rats. Atawia RT; Tadros MG; Khalifa AE; Mosli HA; Abdel-Naim AB Toxicol Lett; 2013 May; 219(2):160-9. PubMed ID: 23500659 [TBL] [Abstract][Full Text] [Related]
34. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment. Nicholson TM; Sehgal PD; Drew SA; Huang W; Ricke WA Differentiation; 2013; 85(4-5):140-9. PubMed ID: 23792768 [TBL] [Abstract][Full Text] [Related]
35. [Rauwolfia extract inhibits the proliferation of prostate cells in rats with benign prostatic hyperplasia]. Liu B; Fang T; Liang L; Hu WJ; Dong M; Chen L; Wu W; Yun SF Zhonghua Nan Ke Xue; 2023 Mar; 29(3):195-201. PubMed ID: 38597699 [TBL] [Abstract][Full Text] [Related]
36. Effect of Veratrum maackii on Testosterone Propionate-Induced Benign Prostatic Hyperplasia in Rats. Park HS; Seo CS; Wijerathne CU; Jeong HY; Moon OS; Seo YW; Won YS; Son HY; Lim JH; Kwun HJ Biol Pharm Bull; 2019 Jan; 42(1):1-9. PubMed ID: 30381617 [TBL] [Abstract][Full Text] [Related]
37. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers. Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707 [TBL] [Abstract][Full Text] [Related]
38. Hormone concentration, metabolic disorders and immunoexpression of androgen and estrogen-alpha receptors in men with benign prostatic hyperplasia and testosterone deficiency syndrome. Ryl A; Rotter I; Slojewski M; Dolegowska B; Grabowska M; Baranowska-Bosiacka I; Laszczynska M Folia Histochem Cytobiol; 2015; 53(3):227-35. PubMed ID: 26400665 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of spontaneous and androgen-induced prostate growth by a nonhypercalcemic calcitriol analog. Crescioli C; Ferruzzi P; Caporali A; Mancina R; Comerci A; Muratori M; Scaltriti M; Vannelli GB; Smiroldo S; Mariani R; Villari D; Bettuzzi S; Serio M; Adorini L; Maggi M Endocrinology; 2003 Jul; 144(7):3046-57. PubMed ID: 12810561 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of the therapeutic effect against benign prostatic hyperplasia and the active constituents from Epilobium angustifolium L. Deng L; Zong W; Tao X; Liu S; Feng Z; Lin Y; Liao Z; Chen M J Ethnopharmacol; 2019 Mar; 232():1-10. PubMed ID: 30529422 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]